EXTRACORPOREAL LIPOPROTEIN(A) ELIMINATION IS ASSOCIATED WITH CAROTID ATHEROSCLEROSIS REGRESSION IN CHD PATIENTS WITH HIGH LIPOPROTEIN(A) LEVELS

被引：0
|
作者：
Safarova, M. [1 ]
Ezhov, M. [1 ]
Afanasieva, O. [2 ]
Balakhonova, T. [3 ]
Konovalov, G. [4 ]
Pokrovsky, S. [2 ]
机构：
[1] Russian Cardiol Res Complex, Atherosclerosis Dept, Moscow, Russia
[2] Russian Cardiol Res Complex, Lab Atherosclerosis, Moscow, Russia
[3] Russian Cardiol Res Complex, Dept Diagnost Ultrasound, Moscow, Russia
[4] MEDSI Clin, Ctr Extracorporeal Therapies, Moscow, Russia
来源：
ATHEROSCLEROSIS | 2014年 / 235卷 / 02期
关键词：
D O I：
10.1016/j.atherosclerosis.2014.05.249
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS-0208
引用
收藏
页码：E93 / E94
页数：2
相关论文
共 50 条
  • [1] Extracorporeal lipoprotein(a) elimination for coronary atherosclerosis regression in coronary heart disease patients with elevated lipoprotein(a) levels
    Safarova, M. S.
    Matchin, Y. U. G.
    Ezhov, M. V.
    Khaustov, A. I.
    Afanasieva, M. I.
    Atanesyan, R. V.
    Utkina, E. A.
    Konovalov, G. A.
    Pokrovsky, S. N.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 447 - 448
  • [2] Association of lipoprotein(a) and apolipoprotein(a) phenotypes with coronary and carotid atherosclerosis in CHD men
    Ezhov, MV
    Afanasyeva, OI
    Benevolenskaya, GF
    Savchenko, AP
    Balakhonova, TV
    Lyakishev, AA
    Pokrovsky, SN
    [J]. TERAPEVTICHESKII ARKHIV, 2000, 72 (01): : 28 - 32
  • [3] Lipoprotein (a) and Carotid Atherosclerosis in Young Patients With Stroke
    Nasr, Nathalie
    Ruidavets, Jean Bernard
    Farghali, Ahmed
    Guidolin, Brigitte
    Perret, Bertrand
    Larrue, Vincent
    [J]. STROKE, 2011, 42 (12) : 3616 - 3618
  • [4] Carotid atherosclerosis and serum lipoprotein(a) concentrations in patients with NIDDM
    Yamamoto, M
    Egusa, G
    Yamakido, M
    [J]. DIABETES CARE, 1997, 20 (05) : 829 - 831
  • [5] LIPOPROTEIN(A) LEVEL AND AUTOANTIBODIES TO IT IN PATIENTS WITH STENOTIC CAROTID ATHEROSCLEROSIS
    Tmoyan, N.
    Ezhov, M.
    Afanasieva, O.
    Klesareva, E.
    Pogorelova, O.
    Tripoten, M.
    Pokrovsky, S.
    [J]. ATHEROSCLEROSIS, 2019, 287 : E229 - E229
  • [6] LIPOPROTEIN(A) IN PATIENTS WITH CAROTID ATHEROSCLEROSIS AND ISCHEMIC CEREBROVASCULAR DISORDERS
    JOVICIC, A
    IVANISEVIC, V
    IVANOVIC, I
    [J]. ATHEROSCLEROSIS, 1993, 98 (01) : 59 - 65
  • [7] LIPOPROTEIN(A) LEVEL, APOLIPOPROTEIN(A) POLYMORPHISM AND AUTOANTIBODIES AGAINST LIPOPROTEIN(A) IN PATIENTS WITH STENOTIC CAROTID ATHEROSCLEROSIS
    Tmoyan, N. A.
    Afanasieva, O., I
    Ezhov, M., V
    Klesareva, E. A.
    Afanasieva, M., I
    Razova, O. A.
    Balakhonova, T., V
    Pokrovsky, S. N.
    [J]. KARDIOLOGIYA, 2019, 59 (12) : 20 - 27
  • [8] Atherosclerosis regression: Is low-density lipoprotein or high-density lipoprotein the answer?
    Nicholls S.J.
    Tuzcu E.M.
    Nissen S.E.
    [J]. Current Atherosclerosis Reports, 2007, 9 (4) : 266 - 273
  • [9] Lipoprotein oxidation and progression of carotid atherosclerosis
    Salonen, JT
    Nyyssonen, K
    Salonen, R
    PorkkalaSarataho, E
    Tuomainen, TP
    Diczfalusy, U
    Bjorkhem, I
    [J]. CIRCULATION, 1997, 95 (04) : 840 - 845
  • [10] Lipoprotein(a) and apo(a) phenotypes are associated with carotid atherosclerosis in younger coronary heart disease patients
    Afanasieva, O. I.
    Ezhov, M. V.
    Lyakishev, A. A.
    Afanasieva, M. I.
    Kukharchuk, V. V.
    Pokrovsky, S. N.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 35 - 35
12345